Sean M. Clayton's most recent trade in Horizon Therapeutics Plc was a trade of 14,129 Restricted Stock Units done . Disclosure was reported to the exchange on March 1, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Horizon Therapeutics Plc | Sean M. Clayton | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 14,129 | 28,258 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | Sean M. Clayton | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 14,129 | 14,408 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Sean M. Clayton | EVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 110.34 per share. | 01 Mar 2023 | 7,032 | 7,376 (0%) | 0% | 110.3 | 775,911 | Ordinary Shares |
| Horizon Therapeutics Plc | Sean M. Clayton | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 22,997 | 22,997 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Sean M. Clayton | EVP, General Counsel | Purchase of securities on an exchange or from another person at price $ 66.67 per share. | 04 Aug 2022 | 745 | 745 (0%) | 0% | 66.7 | 49,669 | Ordinary Shares |
| Horizon Therapeutics Plc | Sean M. Clayton | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 42,387 | 42,387 | - | - | Restricted Stock Units (RSU) |